Yashoda Hospitals hosts Bronchus 2025 Conference in Hyderabad, uniting global experts to address lung cancer challenges.
Lung cancer remains a leading cause of cancer death globally, with a significant rise in cases among non-smokers attributed ...
The fourth edition of Bronchus 2025, an Interventional Pulmonology Conference, brought together medical experts from across ...
Cancer a life-threatening disease can spread or metastasise from its original location to other parts of the body The lungs are a frequent site of metastasis An oncologist explains why ...
With 44,000 new diagnoses each year, non-small cell lung cancer is the second most frequent neoplasm in Italy after breast ...
MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer ...
Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted ...
BENGALURU: When 52-year-old Rahul (name altered), a non-smoker and fitness enthusiast, started experiencing a persistent cough, he initially thought it was a se ...
A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...
2h
News Medical on MSNAriceum Therapeutics receives FDA’s Orphan Drug Designation for targeted radionuclide cancer treatmentAriceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food ...
A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...
Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results